Establishes the "Hope for Missouri Patients Act"

HB 1206, the "Hope for Missouri Patients Act," creates a legal framework for patients with life-threatening or severely debilitating conditions to access personalized investigational treatments based on their genetic profile. It defines eligibility for patients who have exhausted FDA-approved options, received physician recommendations tied to genomic analysis, and provided detailed written consent. The bill requires facilities to follow specific consent protocols and clarifies that insurers are not obligated to cover these treatments, though they may choose to do so. It also protects healthcare providers from license penalties for recommending such treatments and ensures patients bear costs unless covered by a manufacturer agreement. The law applies only to treatments derived from the patient's unique genetic makeup, excluding those involving embryonic stem cells or abortion-derived materials.